Sponsors (4)
The bill increases domestic control, oversight, and transparency of NIH-funded animal research—keeping funding and oversight in the U.S.—but at the cost of reduced international collaboration, higher onshore research costs, and pressure on domestic facilities.
U.S. researchers, institutions, and state governments receive priority access to NIH funding for animal research, keeping research dollars onshore and increasing domestic research investment.
Hospitals, health systems, and researchers benefit from simpler oversight and compliance because animal research would be concentrated in jurisdictions subject to U.S. animal welfare and research regulations.
U.S. taxpayers gain greater transparency about past spending—roughly $2.2 billion funded foreign animal research from FY2011–FY2021—informing oversight and potential reforms.
Scientists, research collaborators, hospitals, and multinational study teams will face reduced international collaboration and potential slowing of scientific progress because foreign researchers and institutions would be ineligible or subject to restrictive policies, risking disrupted timelines and weaker research outcomes.
U.S. taxpayers and domestic research programs may incur higher costs because relocating or performing animal research in the United States is often more expensive (labor, facilities), increasing the overall price of federally funded studies.
Hospitals, health systems, and research institutions in the U.S. could be strained by concentrated demand on a limited number of animal facilities and local regulatory systems, creating capacity bottlenecks and quality or scheduling pressures.
Based on analysis of 3 sections of legislative text.
Bars NIH from funding any research using live animals unless the work is performed within the United States and its territories.
Prohibits the NIH Director from awarding any grants, contracts, cooperative agreements, or technical assistance for research that uses live animals unless the work is performed within the United States or its territories. The change amends the federal statute that governs NIH award authority to restrict federally supported animal research to domestic locations only. The law rests on findings about past NIH funding to foreign organizations and concerns about lack of on-the-ground oversight overseas. It is a narrow, substantive limitation on where NIH-funded animal research may be carried out rather than a change to funding levels or program authorizations.
Introduced May 19, 2025 by Richard Lynn Scott · Last progress May 19, 2025